$Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis$

Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis

Abstract Introduction The specific pharmacological properties of bisphosphonates have raised concerns about their long-term effects on skeletal fragility that may be related to the total dose of bisphosphonate given. However, the effect of different doses on the incidence of osteoporotic fractures h...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone (New York, N.Y.) N.Y.), 2009-05, Vol.44 (5), p.766-771
Hauptverfasser:	Makras, P, Hamdy, N.A.T, Zwinderman, A.H, Ballieux, B.E.P.B, Papapoulos, S.E
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biological and medical sciences Bisphosphonates Bone Density - drug effects Bone Density Conservation Agents - therapeutic use Bones, joints and connective tissue. Antiinflammatory agents Diaphyseal femoral fracture Diphosphonates - administration & dosage Diphosphonates - therapeutic use Drug Administration Schedule Female Fractures Fractures, Bone - epidemiology Fractures, Bone - etiology Fractures, Bone - prevention & control Fundamental and applied biological sciences. Psychology Humans Injuries of the limb. Injuries of the spine Medical sciences Orthopedics Osteoporosis, Postmenopausal - complications Osteoporosis, Postmenopausal - drug therapy Pamidronate Pharmacology. Drug treatments Postmenopausal osteoporosis Retrospective Studies Traumas. Diseases due to physical agents Vertebrates: anatomy and physiology, studies on body, several organs or systems
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!